Pharma and Biotech
Holding(s) in Company | 21-Nov-2024 | 13:00 | RNS |
Share Incentive Plan - Director/PDMR Shareholding | 12-Nov-2024 | 16:00 | RNS |
Changes to the senior leadership team | 11-Nov-2024 | 07:00 | RNS |
Approval of the transfer of listing category | 06-Nov-2024 | 07:00 | RNS |
Holding(s) in Company | 04-Nov-2024 | 09:00 | RNS |
Issue of Capital and Total Voting Rights | 01-Nov-2024 | 16:00 | RNS |
Founder LTIP - Director/PDMR Notification | 16-Oct-2024 | 12:00 | RNS |
Holding(s) in Company | 15-Oct-2024 | 08:00 | RNS |
Issue of Equity and Total Voting Rights | 15-Oct-2024 | 07:00 | RNS |
Admission to Trading on the London Stock Exchange | 14-Oct-2024 | 10:00 | RNS |
Share Incentive Plan - Director/PDMR Shareholding | 11-Oct-2024 | 16:30 | RNS |
New issue in connection with LTIP awards | 10-Oct-2024 | 08:00 | RNS |
Notice of intention to transfer listing category | 08-Oct-2024 | 07:00 | RNS |
Block Listing Interim Review | 07-Oct-2024 | 18:15 | RNS |
Issue of Equity and Total Voting Rights | 02-Oct-2024 | 09:00 | RNS |
Currency | UK Pounds |
Share Price | 122.80p |
Change Today | 0.40p |
% Change | 0.33 % |
52 Week High | 208.20p |
52 Week Low | 86.55p |
Volume | 1,112,467 |
Shares Issued | 954.11m |
Market Cap | £1,171.65m |
Beta | 1.26 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
No dividends found |
Time | Volume / Share Price |
16:37 | 183,613 @ 122.72p |
17:05 | 100 @ 122.80p |
16:29 | 135 @ 124.00p |
16:29 | 747 @ 123.90p |
16:29 | 469 @ 123.90p |
CEO | Gurdial (Gordon) Sanghera |
CFO | Nick Keher |
You are here: research